By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Janssen Therapeutics 

1125 Trenton-Harbourton Road

Titusville  New Jersey  08560  U.S.A.
Phone: n/a Fax: n/a



Company News
Janssen Therapeutics Announces Funding In Support Of Improved Retention In Care And Access To Treatment For Blacks And African Americans Living With HIV In Southern United States And Other Rural Areas 10/25/2016 9:06:26 AM
Janssen Therapeutics Release: U.S. FDA Approves PREZISTA (Darunavir) For Use In Pregnant Women With HIV 7/18/2016 6:34:56 AM
Janssen Therapeutics Announces Funding For Organizations Focused On Improving Care And Treatment For Vulnerable Populations Living With HIV 3/22/2016 7:39:24 AM
Janssen Therapeutics Release: Your Story, Your HIV Wisdom Brings Together HIV Voices And Supports HIV Community Organizations 9/8/2015 10:16:01 AM
Janssen Therapeutics Submits Supplemental New Drug Application To U.S. FDA For All-Oral, Once-Daily OLYSIO (Simeprevir) In Combination With Sofosbuvir 7/24/2015 7:23:57 AM
Janssen Therapeutics Announces Support For Organizations Focused On Improving Care And Treatment For People Who Inject Drugs Living With HIV And/Or Hepatitis C 4/1/2015 11:30:42 AM
Janssen Therapeutics Release: PREZCOBIX™ (Darunavir/Cobicistat) Approved In The U.S. For The Treatment Of Adults Living With HIV-1 1/30/2015 6:08:55 AM
Johnson & Johnson (JNJ) Announces Collaboration Between Janssen Therapeutics And USAID To Expand Access To Anti-Multidrug-Resistant Tuberculosis (MDR-TB) Compound 12/12/2014 7:39:04 AM
Janssen Therapeutics Announces Recipient of Its Second Point Scholarship for LGBT Students 7/17/2013 8:02:08 AM
Janssen Therapeutics Release: Survey of Participants from Landmark GRACE Trial Provides Patients' Perspectives From an HIV Clinical Study 5/31/2013 9:18:33 AM